Roivant Sciences Ltd. (ROIV) SEC Filings & Financial Intelligence
Roivant Sciences Ltd. (ROIV) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ROIV
CIK: 1635088
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 03/31
State: D0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 3/31/2020 12:00:00 AM
Lead Engagement PartnerAnthony Masherelli
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-11-05 | 2026-11-03 | FORM 4 | 0001635088-26-000123 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-11-05 | — | SCHEDULE 13G/A Filing | 0000315066-26-002842 | View SEC Doc Filr Page |
| 144 | 2026-11-03 | — | 144 Filing | 0001965301-26-000170 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-28 | FORM 4 | 0001635088-26-000120 | View SEC Doc Filr Page |
| 144 | 2026-10-28 | — | 144 Filing | 0001965301-26-000167 | View SEC Doc Filr Page |
| 4 | 2026-10-27 | 2026-10-23 | FORM 4 | 0001635088-26-000118 | View SEC Doc Filr Page |
| 4 | 2026-10-27 | 2026-10-23 | FORM 4 | 0001807359-26-000020 | View SEC Doc Filr Page |
| 4 | 2026-10-27 | 2026-10-23 | FORM 4 | 0001209181-26-000009 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-003714 | View SEC Doc Filr Page |
| 4 | 2026-10-22 | 2026-10-20 | FORM 4 | 0001635088-26-000116 | View SEC Doc Filr Page |
| 8-K | 2026-10-21 | 2026-10-21 | 8-K | 0001140361-26-040332 | View SEC Doc Filr Page |
| 4 | 2026-10-20 | 2026-10-16 | FORM 4 | 0001635088-26-000114 | View SEC Doc Filr Page |
| 4 | 2026-10-20 | 2026-10-16 | FORM 4 | 0001635088-26-000113 | View SEC Doc Filr Page |
| 144 | 2026-10-20 | — | 144 Filing | 0001965301-26-000163 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-10-05 | — | SCHEDULE 13D/A Filing | 0001140361-26-038693 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | FORM 4 | 0001140361-26-038692 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | FORM 4 | 0001807359-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001140361-26-038475 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001140361-26-038474 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001635088-26-000109 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001635088-26-000108 | View SEC Doc Filr Page |
| 144 | 2026-09-30 | — | 144 Filing | 0001965301-26-000150 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-20 | FORM 4 | 0001140361-26-037363 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-20 | FORM 4 | 0001635088-26-000104 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001140361-26-037158 | View SEC Doc Filr Page |